Cite
Elucidating the clinical and molecular spectrum of SMARCC2-associated NDD in a cohort of 65 affected individuals
MLA
Bosch, Elisabeth, et al. “Elucidating the Clinical and Molecular Spectrum of SMARCC2-Associated NDD in a Cohort of 65 Affected Individuals.” Genetics in Medicine, vol. 25, no. 11, Nov. 2023. EBSCOhost, https://doi.org/10.1016/j.gim.2023.100950.
APA
Bosch, E., Popp, B., Güse, E., Skinner, C., van der Sluijs, P. J., Maystadt, I., Pinto, A. M., Renieri, A., Bruno, L. P., Granata, S., Marcelis, C., Baysal, Ö., Hartwich, D., Holthöfer, L., Isidor, B., Cogne, B., Wieczorek, D., Capra, V., Scala, M., … Vasileiou, G. (2023). Elucidating the clinical and molecular spectrum of SMARCC2-associated NDD in a cohort of 65 affected individuals. Genetics in Medicine, 25(11). https://doi.org/10.1016/j.gim.2023.100950
Chicago
Bosch, Elisabeth, Bernt Popp, Esther Güse, Cindy Skinner, Pleuntje J. van der Sluijs, Isabelle Maystadt, Anna Maria Pinto, et al. 2023. “Elucidating the Clinical and Molecular Spectrum of SMARCC2-Associated NDD in a Cohort of 65 Affected Individuals.” Genetics in Medicine 25 (11). doi:10.1016/j.gim.2023.100950.